Possibility of magnesium supplementation for supportive treatment in patients with COVID-19

CF Tang, H Ding, RQ Jiao, XX Wu, LD Kong - European journal of …, 2020 - Elsevier
Magnesium as an enzymatic activator is essential for various physiological functions such as
cell cycle, metabolic regulation, muscle contraction, and vasomotor tone. A growing body of …

Cisplatin mouse models: treatment, toxicity and translatability

M Perše - Biomedicines, 2021 - mdpi.com
Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide
range of pediatric and adult malignances. However, it has various side effects which limit its …

β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress

S Luo, M Yang, Y Han, H Zhao, N Jiang, L Li… - International …, 2022 - Elsevier
Cisplatin, as a commonly used anticancer drug, can easily lead to acute kidney injury (AKI),
and has received more and more attention in clinical practice. β-hydroxybutyric acid (BHB) is …

[HTML][HTML] Current role of nanoparticles in the treatment of lung cancer

E Carrasco-Esteban… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Background: Worldwide, lung cancer is one of the leading causes of cancer death.
Nevertheless, new therapeutic agents have been developed to treat lung cancer that could …

Reactive Oxygen Species- and Cell-Free DNA-Scavenging Mn3O4 Nanozymes for Acute Kidney Injury Therapy

L Meng, J Feng, J Gao, Y Zhang, W Mo… - … Applied Materials & …, 2022 - ACS Publications
Reactive oxygen species (ROS) scavenging therapy toward acute kidney injury (AKI) is
promising, but no effective ROS scavenging drug has been developed yet. Moreover, cell …

Pro-inflammatory signalling PRRopels cisplatin-induced toxicity

IK Domingo, A Latif, AP Bhavsar - International journal of molecular …, 2022 - mdpi.com
Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a
variety of solid-cancers, substantially improving the five-year survival rates for cancer …

Matrine alleviates cisplatin‐induced acute kidney injury by inhibiting mitochondrial dysfunction and inflammation via SIRT3/OPA1 pathway

L Yuan, J Yang, Y Li, L Yuan, F Liu… - Journal of Cellular …, 2022 - Wiley Online Library
Cisplatin is extensively used to treat malignancies. However, its clinical use is always limited
due to the serious side effects, especially the nephrotoxicity. Matrine (MAT), a tetracyclic …

Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine

P Lou, S Liu, Y Wang, K Lv, X Zhou, L Li… - Advanced …, 2023 - Wiley Online Library
Extracellular vesicle (EV)‐based therapies have emerged as a promising means in
regenerative medicine. However, the conventional EV therapy strategy displays some …

Conventional chemotherapy nephrotoxicity

S Gupta, I Portales-Castillo, A Daher… - Advances in Chronic …, 2021 - Elsevier
Conventional chemotherapies remain the mainstay of treatment for many malignancies.
Kidney complications of these therapies are not infrequent and may have serious …

Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential

N Alassaf, H Attia - Frontiers in Pharmacology, 2023 - frontiersin.org
Cisplatin (CP) is a broad-spectrum antineoplastic agent, used to treat many different types of
malignancies due to its high efficacy and low cost. However, its use is largely limited by …